Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to ...

Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

In a call with investors, CEO Gail Boudreaux didn’t directly address the killing of UnitedHealthcare’s top executive but spent more time than usual arguing Elevance is working to improve healthcare.

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit $5.98 billion, almost identical to its total a year ago. Operating revenue ...

Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...

Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded ...